Why the president of Kroger Health is betting the grocery giant can use food as medicinenews2023-12-12T13:00:15+00:00December 12th, 2023|Endpoints News|
Tome Biosciences launches with $213M to develop gene insertion therapies based on MIT technologynews2023-12-12T12:57:05+00:00December 12th, 2023|Endpoints News|
Exclusive: Shinobi raises $51M to take on cell therapy challenges with ex-Wugen CEO at helm, Carl June in supportnews2023-12-12T12:30:26+00:00December 12th, 2023|Endpoints News|
Pfizer to complete Seagen acquisition Thursday, Angela Hwang to depart amid executive shufflenews2023-12-12T12:27:33+00:00December 12th, 2023|Endpoints News|
Bristol Myers bags SystImmune’s lung cancer drug for $800M upfront in its third ADC-focused pact of 2023news2023-12-12T12:01:07+00:00December 12th, 2023|Endpoints News|
Exclusive: Women’s health biotech Freya Biosciences raises $38M for microbial immunotherapiesnews2023-12-12T12:00:37+00:00December 12th, 2023|Endpoints News|
Biocon oncology spinout Bicara secures its second nine-figure financing of the yearnews2023-12-12T11:30:13+00:00December 12th, 2023|Endpoints News|
AstraZeneca to acquire Icosavax for $800M+ upfront, bagging virus-like particle platform and late-stage RSV vaccinenews2023-12-12T10:53:34+00:00December 12th, 2023|Endpoints News|
Biotech CAR-T roundup: Autolus, Gracell tout early-stage data at ASHnews2023-12-12T09:56:58+00:00December 12th, 2023|Endpoints News|
Bristol Myers and 2seventy bio’s Abecma survival data raise questions ahead of FDA’s adcommnews2023-12-12T00:30:20+00:00December 12th, 2023|Endpoints News|
